On June 30, the major project commissioning and project signing activities of Xingong Tairong Bioreagent Industry Cluster were held in Binjiang Development Zone. 24 new pharmaceutical and life and health industry chain companies signed contracts and settled in the area.
As the first common manufacturing platform for new medicine and life and health industries in Nanjing, Xingong Tairong Biological Reagent Industry Cluster is jointly invested by Nanjing Xingong Investment Group and its subsidiary Jiangsu Kaiji Biotechnology Co., Ltd. in Binjiang Development Zone. The project will focus on the new medicine and life and health industry chain, focusing on building upstream key raw material bases such as antibody drugs, recombinant protein drugs, and diagnostic reagents. Since the project was signed and settled in Binjiang Development Zone, it has been listed as a key national medical strategic material energy and material reserve project, "Jiangsu Provincial Biomedicine Core Materials Green Manufacturing Innovation Base" and "Nanjing Industrial Chain Public Technical Services" platform". It is expected that after the project is fully completed, it will gather 30-50 key enterprises in the industry and implement 80 industrialization projects. It will create a highly influential landmark industry, further enhance the industrial energy level and development quality and efficiency, and provide a high-quality development platform for Binjiang Development Zone. Provide strong support for quality development.
(Source: Jiangning District People’s Government website) [For submissions and regional cooperation, please email Information Newspaper 3469887933#qq.com to reply within 24 hours. 】
- Read
- Hide sidebar
Release date: 2022-07-01 20:08:57 Category: Headlines
